Hartmut Grasemann

Jul 18, 2024 | journals.asm.org | Hartmut Grasemann |Valerie Waters

1. Scott JA, Maarsingh H, Holguin F, Grasemann H. 2021. Arginine therapy for lung diseases. Front Pharmacol 12:627503. 2. Grasemann H, Schwiertz R, Matthiesen S, Racké K, Ratjen F. 2005. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 172:1523–1528. 3. Grasemann H, Schwiertz R, Grasemann C, Vester U, Racké K, Ratjen F. 2006. Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. Respir Res 7:87. 4. Durante W, Johnson FK, Johnson RA. 2007.

Mar 15, 2023 | thorax.bmj.com | Lucy Mary Perrem |Sanja Stanojevic |Melinda Solomon |Hartmut Grasemann

Twitter @luperr84Contributors LP contributed to conceptualisation of the study design, data collection, data analysis, data interpretation, figures and wrote the manuscript. SS contributed to conceptualisation and design of the study, funding acquisition, data analysis, data interpretation, figures and manuscript review and editing; SDD contributed to funding acquisition, study design, data interpretation and manuscript review and editing.